Literature DB >> 17392730

Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype.

A Gaedigk1, J D Eklund, R E Pearce, J S Leeder, S W Alander, M S Phillips, L D Bradford, M J Kennedy.   

Abstract

A 5-year-old African-American girl presented with a CYP2D6*4xN/*10 genotype that was discordant with her poor metabolizer phenotype determined with the probe drug dextromethorphan. Both phenotype and genotype were confirmed in repeat assessments, suggesting that the CYP2D6*10 allele carried a novel debilitating sequence variation(s). The rationale for this study was to resolve the discordance and to describe the novel non-functional allelic variant of CYP2D6 and its frequency in populations of different ethnic backgrounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392730     DOI: 10.1038/sj.clpt.6100125

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  Prediction of drug response and safety in clinical practice.

Authors:  Andrew A Monte; Kennon J Heard; Vasilis Vasiliou
Journal:  J Med Toxicol       Date:  2012-03

2.  Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.

Authors:  Alison Fohner; LeeAnna I Muzquiz; Melissa A Austin; Andrea Gaedigk; Adam Gordon; Timothy Thornton; Mark J Rieder; Mark A Pershouse; Elizabeth A Putnam; Kevin Howlett; Patrick Beatty; Kenneth E Thummel; Erica L Woodahl
Journal:  Pharmacogenet Genomics       Date:  2013-08       Impact factor: 2.089

3.  CYP2D6 Haplotype Determination Using Long Range Allele-Specific Amplification: Resolution of a Complex Genotype and a Discordant Genotype Involving the CYP2D6*59 Allele.

Authors:  Andrea Gaedigk; Amanda K Riffel; J Steven Leeder
Journal:  J Mol Diagn       Date:  2015-09-01       Impact factor: 5.568

Review 4.  Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.

Authors:  Victoria M Pratt; Larisa H Cavallari; Andria L Del Tredici; Andrea Gaedigk; Houda Hachad; Yuan Ji; Lisa V Kalman; Reynold C Ly; Ann M Moyer; Stuart A Scott; R H N van Schaik; Michelle Whirl-Carrillo; Karen E Weck
Journal:  J Mol Diagn       Date:  2021-06-10       Impact factor: 5.341

5.  Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study.

Authors:  Tyren M Dodgen; Warren E Hochfeld; Heidi Fickl; Sahle M Asfaha; Chrisna Durandt; Paul Rheeder; Britt I Drögemöller; Galen E B Wright; Louise Warnich; Christiaan D J Labuschagne; Antoinette van Schalkwyk; Andrea Gaedigk; Michael S Pepper
Journal:  BMC Med Genet       Date:  2013-01-29       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.